2) TRPC1 expression is positively associated with TNM stage in NSCLC patients currently; besides, patients receiving adjuvant chemotherapy are usually diagnosed with a more advanced TNM stage compared with those who do not receive adjuvant chemotherapy; meanwhile, patients responding to adjuvant chemotherapy might reach a declined TNM stage. Here, TRPC1 is linked to non-small cell lung carcinoma.